BioHarvest Sciences Inc. (CSE:BHSC) (the “Company”) announces today the appointment of Mr. Ilan Sobel as the Chief Executive Officer replacing Dr. Zaki Rakib in this role. Dr. Rakib will assume the new positions of President and Chairman of the Board and as such Mr. Dave Ryan, previously President, will assume the role of Vice President of Investor Relations. The appointment of Mr. Sobel and the changes listed above are effective immediately.

“The merger of BioHarvest Ltd. with Canna-V-Cell Sciences Inc. completed late March, creates a great opportunity for the Company to leverage its proprietary Biofarming technology in multiple verticals that include Cannabis and Nutraceuticals,” said Dr. Zaki Rakib, and added, “Such opportunities require the best management team to address. BioHarvest is fortunate to bring Ilan Sobel as its CEO to lead the Company at such an important junction. Ilan brings a wealth of hands-on experience, business acumen and leadership expertise in building large-scale businesses and billion-dollar brands, delivering margin-enhancing business innovation and driving productivity improvements for some of the biggest industry leaders across diverse markets. On behalf of the Board of Directors and the Management, I welcome Ilan to the team and look forward to partnering with him on our exciting journey of building BioHarvest Sciences’ business.”

“I am honored and grateful to have this opportunity to lead a great team with such a technological platform which has the real ability to positively impact the lives of millions of consumers,” said Ilan Sobel and, continued, “I am looking forward to building on the early success of VINIA®, one of the world first natural vasodilator without sugar and calories and in the future, following our completion of critical R&D work, having the ability to change the cannabis market with the supply of consistent, homogenous cannabis at a fraction of today’s industry cost.”

Ilan Sobel, brings to the Company extensive experience in General Management, International Sales and Marketing, Manufacturing and Operations. For the past 6 years, Ilan served as Chief Operating Officer and then Chief Commercial Officer of Weissbeerger, where he played a major leadership role in building a disruptive BIG Data, IOT & Software Company servicing major Beverage players which was recently purchased by Anheuser Busch InBev. Previously, Ilan served an 18 year stint as an International Employee of The Coca-Cola Company, where he played a pivotal role in key senior leadership positions generating significant revenue and profit growth and improving brand health trends across diverse global markets including the United States, China, Hong Kong, Taiwan, Thailand, Singapore, Malaysia, Vietnam, the Philippines and South Africa.

Under the terms of a Consulting Agreement dated for reference June 1st, 2020, the Company will pay Mr. Sobel a consulting fee of $ 34,547 per month subject to annual increases over the 3 year term of the Agreement and annual bonus based on performance. The Company has also agreed to grant Mr. Sobel options to acquire a total of 18,098,196 common shares of the Company at a price of $0.14 per share. The options will be exercisable for a 10 year period and will vest quarterly over the term of the consulting agreement.

About BioHarvest Sciences Inc.

Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent protected Biofarming technology. It is the first and only industrial large-scale plant cell growth technology capable of directly and constantly producing the active plant ingredients without the necessity to grow the plant itself. The technology has been already validated by Vinia, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest. By adapting this technology to the Cannabis plant, and building adequate cells production capacity, BioHarvest Sciences Inc.’s objective is to become the leading supplier of Cannabis for both the medicinal and recreational legal use. See the following hyperlink for a visual description of our Biofarming technology:

BioHarvest Sciences Inc.

Dr. Zaki Rakib
President and Chairman of the Board

For further information, please contact:

Dave Ryan, VP Investor Relations & Director
Phone: 1 (604) 622-1186

Forward-Looking Statements Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information.

Neither Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release


Learn how to invest in life science and medical stocks

Read your free starter guide to investing in life science

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less